MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0006407
Scoria Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.09 Cr
▼ 10% YoY
Net profit · FY 2025
₹1.17 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹4.16 Lakh
EBITDA margin 3.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹9.74 Lakh
Company age
23 yrs
Est. 2003
Directors on board
2
As per MCA filings
About Scoria Pharmaceuticals Private Limited
Data last updated:
Scoria Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC121713. Its GSTIN is 07AAHCS5581N1ZO (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Surjeet Ray and Shashi Dhiman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz – 295 2nd Floor Gali No 10 Lajwanti Garden, New Delhi, Delhi, India – 110046.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.09 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.17 Lakh (net margin 1.1%) and EBITDA of ₹4.16 Lakh (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹9.74 Lakh on record.
Scoria Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0006407). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website scoriapharmaceuticals.com.
Company details
CIN U24239DL2003PTC121713
Registration Number 121713
Incorporation Date 08 August 2003
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0006407
Key People
Surjeet Ray Director Shashi Dhiman Director Recognitions & Rankings of Scoria Pharmaceuticals
Contact details
Scoria Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is scoriapharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressWz – 295 2nd Floor Gali No 10 Lajwanti Garden, New Delhi, Delhi, India – 110046
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Scoria Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Scoria Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Scoria Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Scoria Pharmaceuticals Private Limited, buy the company report.
Financials of Scoria Pharmaceuticals Private Limited
FY 2025 filings availableScoria Pharmaceuticals Private Limited reported revenue of ₹1.09 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹1.09 Cr ▼ 10%
Net profit · FY 2025
₹1.17 Lakh margin 1.1%
EBITDA · FY 2025
₹4.16 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 11%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▲ 77%
3 years · compounded
▼ 15%
5 years · compounded
▲ 13%
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 10% fall in the latest year. EBITDA rose 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scoria Pharmaceuticals Private Limited, buy the company report.
Board of directors of Scoria Pharmaceuticals Private Limited
Scoria Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surjeet Ray | Director | 10 Oct 2018 | 8 Years 0 Months | Current |
| Shashi Dhiman | Director | 31 Oct 2015 | 11 Years 0 Months | Current |
Auditor
Scoria Pharmaceuticals Private Limited is audited by VIMAL TANEJA MALLICK & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIMAL TANEJA MALLICK & ASSOCIATES | FY 2021 | 009957N |
Shareholding
The shareholding of Scoria Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Scoria Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
₹9.74 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Oct 2013 | 10456490 | Punjab National Bank | ₹50 Lakh | Open | |
| 10 Jul 2020 | 100356277 | Others | ₹9.74 Lakh | Satisfied |
To see the full charge records of Scoria Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Scoria Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scoria Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Scoria Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCS5581N1ZO | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Scoria Pharmaceuticals Private Limited, buy the company report.
Recent activity
Scoria Pharmaceuticals Private Limited has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Hari Shanker ceased to be Director on 10 Nov 2018.
Charges
A charge registered on 10 Jul 2020 via Charge ID 100356277 with Others was fully satisfied on 15 Jan 2026.
AGM
Scoria Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Scoria Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 9.74 Lakh with Charge ID 100356277 was registered on 10 Jul 2020.
Ceased
Hari Shanker ceased to be Director.
Appointed
Surjeet Ray was appointed as Director.
Ceased
Surjeet Ray ceased to be Director.
Ceased
Shashi Dhiman ceased to be Additional Director.
Ceased
Kunal Kumar Dhiman ceased to be Director.
Appointed
Shashi Dhiman was appointed as Director.
Charges
A charge with Punjab National Bank of Rs. 50.00 Lakh registered on 25 Oct 2013 with Charge ID 10456490 was modified on 27 May 2015.
Charges
A charge with Punjab National Bank amounted to Rs. 50.00 Lakh with Charge ID 10456490 was registered on 25 Oct 2013.
2 earlier events are in the company report.
Frequently asked questions
Scoria Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2003 (23+ years old) and is registered under CIN U24239DL2003PTC121713.
Scoria Pharmaceuticals has 2 current directors:
- Surjeet Ray - Director
- Shashi Dhiman - Director
The latest financial statements of Scoria Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Scoria Pharmaceuticals is 07AAHCS5581N1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of Scoria Pharmaceuticals is U24239DL2003PTC121713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scoria Pharmaceuticals was incorporated on 08 August 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Hari Shanker ceased to be Director on 10 Nov 2018. Surjeet Ray was appointed as Director on 10 Oct 2018. Surjeet Ray ceased to be Director on 31 Dec 2016. Scoria Pharmaceuticals has 7 board changes on record in total.
Yes, Scoria Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0006407).
Scoria Pharmaceuticals can be reached through the website scoriapharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Scoria Pharmaceuticals is at Wz – 295 2nd Floor Gali No 10 Lajwanti Garden, New Delhi, Delhi, India – 110046.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages